Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 20;13(2):147.
doi: 10.3390/v13020147.

Novel Flavivirus Attenuation Markers Identified in the Envelope Protein of Alfuy Virus

Affiliations

Novel Flavivirus Attenuation Markers Identified in the Envelope Protein of Alfuy Virus

Daniel Westlake et al. Viruses. .

Abstract

Alfuy (ALFV) is an attenuated flavivirus related to the Murray Valley encephalitis virus (MVEV). We previously identified markers of attenuation in the envelope (E) protein of the prototype strain (ALFV3929), including the hinge region (E273-277) and lack of glycosylation at E154-156. To further determine the mechanisms of attenuation we assessed ALFV3929 binding to glycosaminoglycans (GAG), a known mechanism of flaviviruses attenuation. Indeed, ALFV3929 exhibited reduced binding to GAG-rich cells in the presence of heparin; however, low-passage ALFV isolates were relatively unaffected. Sequence comparisons between ALFV strains and structural modelling incriminated a positively-charged residue (K327) in ALFV3929 as a GAG-binding motif. Substitution of this residue to the corresponding uncharged residue in MVEV (L), using a previously described chimeric virus containing the prM & E genes of ALFV3929 in the backbone of MVEV (MVEV/ALFV-prME), confirmed a role for K327 in enhanced GAG binding. When the wild type residues at E327, E273-277 and E154-156 of ALFV3929 were replaced with the corresponding residues from virulent MVEV, it revealed each motif contributed to attenuation of ALFV3929, with the E327/E273-277 combination most dominant. These data demonstrate that attenuation of ALFV3929 is multifactorial and provide new insights for the rational design of attenuated flavivirus vaccines.

Keywords: Alfuy virus (ALFV); Murray Valley encephali-tis virus (MVEV); attenuation; flavivirus; glycosaminoglycan (GAG).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Heparin inhibition by of ALFV3929 and other small plaque ALFV derivatives. Viruses were incubated with heparin (50 µg/mL or 200 µg/mL) for 15 min prior to their addition to SW13 (A,C) or C6/36 (B,D) cell monolayers. Error bars indicate the standard deviation values calculated for each triplicate. DM stands for the double mutant which contains the MVEV sequence in both the hinge and glycosylation sites. Percentage inhibition of titre caused by heparin was calculated as follows: 100 − (TCID50 in the presence of heparin/TCID50 of mock treated control) × 100%. MVE/ALFVstr-K327Q-DM = MVE/ALFstr-CHO+/HMVEV/K327Q, MVE/ALFstr-K327Q-Hinge = MVE/ALFstr-HMVEV/K327Q.
Figure 2
Figure 2
Computer generated map of the surface of E protein Domain III. Surface map was generated by Swiss-Pdb-Viewer Ver.4.0.4. Electrostatic potential was calculated using the Poisson-Boltzmann method. Blue indicates a positive charge, while red indicates a negative charge.
Figure 3
Figure 3
Growth kinetics of glycosaminoglycans GAG mutants. Growth kinetics of Murray Valley encephalitis virus (MVEV), ALFV3929 MVE/ALFVstr and associated mutants on PS-EK (A), Vero (B) and SW-13 cells (C). Cells infected at an m.o.i of 0.1, viral titre determined by TCID50 on C6/36 cells.
Figure 4
Figure 4
Kaplan-Meier survival curves of Swiss mice inoculated i.p. with 105 infectious units with MVEV/ALFVstr and associated mutants. (n = 10) p-Value is 0.0195. Curves produced using GraphPad Prism Ver.5.0.

Similar articles

Cited by

References

    1. May F.J., Lobigs M., Lee E., Gendle D.J., Mackenzie J.S., Broom A.K., Conlan J.V., Hall R.A. Biological, antigenic and phylogenetic characterization of the flavivirus Alfuy. J. Gen. Virol. 2006;87:329–337. doi: 10.1099/vir.0.81252-0. - DOI - PubMed
    1. Mackenzie J.S., Williams D.T. The Zoonotic Flaviviruses of Southern, South-Eastern and Eastern Asia, and Australasia: The Potential for Emergent Viruses. Zoonoses Public Health. 2009;56:338–356. doi: 10.1111/j.1863-2378.2008.01208.x. - DOI - PubMed
    1. Mukhopadhyay S., Kuhn R.J., Rossmann M.G. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 2005;3:13–22. doi: 10.1038/nrmicro1067. - DOI - PubMed
    1. Gollins S.W., Porterfield J.S. Flavivirus infection enhancement in macrophages: An electron microscopic study of viral cellular entry. J. Gen. Virol. 1985;66:1969–1982. doi: 10.1099/0022-1317-66-9-1969. - DOI - PubMed
    1. Chen Y., Maguire T., Marks R.M. Demonstration of binding of dengue virus envelope protein to target cells. J. Virol. 1996;70:8765–8772. doi: 10.1128/JVI.70.12.8765-8772.1996. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources